Latest Varian Medical Systems Stories
PALO ALTO, Calif., Nov. 5, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is scheduled to present at Jefferies 2012 Global Healthcare Conference at 10:40 a.m. GMT on Thursday, November 15, at the Waldorf Hilton in London. Participating executives will be Spencer Sias, vice president of investor relations and corporate communications, and Neil Madle, director of investor relations Europe. The presentation will focus on the company's growth opportunities in radiation...
MOSCOW, Nov. 2, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), the world leader in radiotherapy equipment and software for treating cancer, is reinforcing its commitment to the Russian Federation by actively seeking Russia-based suppliers and local R&D collaborations. At this week's Open Innovations Forum in Moscow, Varian is holding a joint supplier conference with local organizations the Skolkovo and Rusnano Foundations to explain its strategy for the Russian market...
BOSTON, Oct. 31, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) highlighted the company's technologies for the non-invasive treatment of lung cancer at the 54(th) annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston this week. Many of Varian's cancer treatment systems can be utilized for attacking lung tumors--which often move during treatment--very precisely, with carefully-shaped, high dose X-ray beams. "Our latest treatment systems have...
BOSTON, Oct. 31, 2012 /PRNewswire/ -- The American Board of Radiology Foundation (ABRF) and Varian Medical Systems (NYSE: VAR) today announce that Varian is awarding a $100,000 grant to the ABRF to establish a national brachytherapy registry. The new registry, which is the first such nationwide modality-based project in radiation oncology, is linked to the American Board of Radiology's (ABR's) Innovation Pathway in Maintenance of Certification (MOC) for Focused Practice Recognition of...
BOSTON, Oct. 30, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR), the leading provider of oncology software, today announced the launch of a portfolio of oncology-specific information technology (IT) solutions designed to meet the requirements of a modern cancer treatment center. The company's FullScale(TM) oncology IT portfolio comprises a flexible set of comprehensive IT solutions for every type of healthcare delivery system, from a single-site clinic...
BOSTON, Oct. 29, 2012 /PRNewswire/ -- Despite weather concerns here at the meeting of the American Society for Radiation Oncology (ASTRO), Varian Medical Systems (NYSE: VAR) is planning to proceed with its scheduled investor meeting and webcast at 7:00 a.m. Eastern time tomorrow, October 30. It will also conduct a planned tour of its ASTRO exhibit following the meeting if the convention hall is open. "We realize that many who were planning to attend will not be able to make it...
BOSTON, Oct. 29, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) yesterday unveiled its next move against cancer, the new EDGE(TM) Radiosurgery Suite(*) -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining...
BOSTON, Oct. 28, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) today unveiled its next move against cancer, the new EDGE(TM) Radiosurgery Suite(*) -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining...
PALO ALTO, Calif., Oct. 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today is reporting net earnings from continuing operations of $1.08 per diluted share in the fourth quarter of fiscal year 2012, up 14 percent from $0.95 in the year-ago quarter. Net earnings per diluted share from continuing operations for fiscal year 2012 climbed to $3.76, up 9 percent from $3.44 in fiscal year 2011. Varian's company-wide revenues totaled $756 million for the fourth quarter of...
PALO ALTO, Calif., Oct. 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Advanced Particle Therapy LLC (APT) and its Special Purpose Company, Georgia Proton Treatment Center, LLC today announced that they have signed an agreement by which Varian will provide its ProBeam system for the Georgia Proton Treatment Center, slated to be built in midtown Atlanta. The Center will be operated by Emory Healthcare. The supply agreement, valued at $83 million, covers technology...
